Cigna Group $CI Shares Bought by Tri Locum Partners LP

Key Points

• Tri Locum Partners LP increased its ownership in Cigna Group by 81.1% during the first quarter, now holding 73,905 shares worth approximately $24.31 million, making Cigna its largest investment.
• Several analysts have revised their price targets for Cigna Group, with Piper Sandler raising it to $374.00 and Barclays lowering it to $354.00, reflecting varied market perspectives.
• Cigna Group recently declared a quarterly dividend of $1.51 per share, resulting in an annualized yield of 2.0%, with a payout ratio of 32.97%.

Tri Locum Partners LP boosted its holdings in Cigna Group (NYSE:CI - Free Report) by 81.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 73,905 shares of the health services provider's stock after acquiring an additional 33,095 shares during the quarter. Cigna Group comprises about 12.5% of Tri Locum Partners LP's investment portfolio, making the stock its biggest holding. Tri Locum Partners LP's holdings in Cigna Group were worth $24,315,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Lansforsakringar Fondforvaltning AB publ raised its holdings in Cigna Group by 27.5% during the 1st quarter. Lansforsakringar Fondforvaltning AB publ now owns 3,474 shares of the health services provider's stock worth $1,143,000 after buying an additional 750 shares during the period. Northstar Financial Companies Inc. acquired a new stake in Cigna Group during the 1st quarter worth about $234,000. Oak Associates Ltd. OH raised its holdings in Cigna Group by 0.3% during the 1st quarter. Oak Associates Ltd. OH now owns 46,478 shares of the health services provider's stock worth $15,291,000 after buying an additional 132 shares during the period. Ieq Capital LLC raised its holdings in Cigna Group by 141.5% during the 1st quarter. Ieq Capital LLC now owns 25,607 shares of the health services provider's stock worth $8,425,000 after buying an additional 15,002 shares during the period. Finally, Samalin Investment Counsel LLC raised its holdings in Cigna Group by 2.2% during the 1st quarter. Samalin Investment Counsel LLC now owns 1,792 shares of the health services provider's stock worth $590,000 after buying an additional 39 shares during the period. Institutional investors and hedge funds own 86.99% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on CI shares. Wall Street Zen downgraded Cigna Group from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Barclays lowered their target price on Cigna Group from $385.00 to $354.00 and set an "overweight" rating on the stock in a research note on Friday, August 1st. Robert W. Baird set a $372.00 target price on Cigna Group in a research note on Thursday, August 14th. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $371.00 target price on shares of Cigna Group in a research note on Thursday, June 26th. Finally, Wells Fargo & Company lowered their target price on Cigna Group from $341.00 to $340.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 14th. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat, Cigna Group has a consensus rating of "Buy" and an average price target of $374.82.

Cigna Group Stock Up 0.8%

Shares of NYSE CI traded up $2.39 during trading hours on Monday, hitting $301.39. The stock had a trading volume of 1,588,821 shares, compared to its average volume of 1,802,228. The company has a market capitalization of $80.45 billion, a P/E ratio of 16.45, a P/E/G ratio of 0.88 and a beta of 0.48. The firm's 50-day moving average price is $299.56 and its two-hundred day moving average price is $311.93. Cigna Group has a 52 week low of $256.89 and a 52 week high of $370.83. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating the consensus estimate of $7.15 by $0.05. The business had revenue of $67.13 billion during the quarter, compared to analysts' expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm's quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th will be given a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. Cigna Group's dividend payout ratio is presently 32.97%.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the company's stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares of the company's stock, valued at $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is owned by insiders.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.